We are live on
!
Find out more
QC
Quadrature Capital Portfolio holdings
AUM
$8.4B
1-Year Est. Return
63.34%
This Fund
S&P 500
This Quarter
Est. Return
+10.07%
1 Year Est. Return
+63.34%
3 Year Est. Return
+138.13%
5 Year Est. Return
+102.94%
10 Year Est. Return
+462.02%
AUM
$8.4B
AUM Growth
-$1.39B
(-14%)
Cap. Flow
-$1.42B
Cap. Flow
% of AUM
-16.87%
Top 10 Holdings %
Top 10 Hldgs %
24.29%
Holding
2,005
New
788
Increased
262
Reduced
256
Closed
692
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$241M |
| 2 |
Microsoft
MSFT
|
+$174M |
| 3 |
SAP
SAP
|
+$166M |
| 4 |
CrowdStrike
CRWD
|
+$137M |
| 5 |
Intel
INTC
|
+$128M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SNDK
Sandisk
SNDK
|
+$307M |
| 2 |
Canadian National Railway
CNI
|
+$187M |
| 3 |
GE Vernova
GEV
|
+$183M |
| 4 |
Netflix
NFLX
|
+$156M |
| 5 |
Eli Lilly
LLY
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.56% |
| 2 | Financials | 13.23% |
| 3 | Consumer Discretionary | 9.27% |
| 4 | Healthcare | 8.86% |
| 5 | Industrials | 6.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Adaptive Biotechnologies
ADPT
$3.56B
| $172K | ﹤0.01% |
+12,387
| New | +$197K |
|
1152
Vaalco Energy
EGY
$594M
| $170K | ﹤0.01% |
+26,788
| New | +$135K |
|
1153
Ooma
OOMA
$550M
| $169K | ﹤0.01% |
+11,635
| New | +$146K |
|
1154
Imperial Petroleum
IMPP
$215M
| $168K | ﹤0.01% |
+39,203
| New | +$157K |
|
|
CTNM
1155
Contineum Therapeutics
CTNM
$526M
| $167K | ﹤0.01% |
12,799
-10,578
| -45% | -$142K |
|
1156
Neumora Therapeutics
NMRA
$276M
| $166K | ﹤0.01% |
85,324
+73,939
| +649% | +$192K |
|
|
RC
1157
Ready Capital
RC
$265M
| $165K | ﹤0.01% |
101,979
-73,016
| -42% | -$140K |
|
1158
C4 Therapeutics
CCCC
$376M
| $165K | ﹤0.01% |
62,760
-70,352
| -53% | -$166K |
|
1159
Prime Medicine
PRME
$533M
| $163K | ﹤0.01% |
46,893
-5,973
| -11% | -$22.7K |
|
1160
Ascent Industries
ACNT
$137M
| $162K | ﹤0.01% |
12,198
-12,691
| -51% | -$197K |
|
|
DDL
1161
Dingdong
DDL
$529M
| $162K | ﹤0.01% |
+63,172
| New | +$176K |
|
1162
Blend Labs
BLND
$409M
| $160K | ﹤0.01% |
+94,256
| New | +$201K |
|
1163
Cushman & Wakefield Ltd
CWK
$2.98B
| $160K | ﹤0.01% |
+13,065
| New | +$187K |
|
1164
Clover Health Investments
CLOV
$2.28B
| $156K | ﹤0.01% |
88,805
+76,651
| +631% | +$166K |
|
1165
PagerDuty
PD
$700M
| $155K | ﹤0.01% |
24,961
-36,811
| -60% | -$318K |
|
1166
Noodles & Co
NDLS
$90.5M
| $153K | ﹤0.01% |
+17,883
| New | +$106K |
|
1167
Tronox
TROX
$995M
| $152K | ﹤0.01% |
15,574
-3,707
| -19% | -$25.7K |
|
1168
Lesaka Technologies
LSAK
$388M
| $152K | ﹤0.01% |
+29,858
| New | +$141K |
|
1169
Seanergy Maritime Holdings
SHIP
$351M
| $152K | ﹤0.01% |
11,754
-2,995
| -20% | -$35.1K |
|
1170
Cullinan Oncology
CGEM
$1.05B
| $150K | ﹤0.01% |
+10,577
| New | +$136K |
|
1171
Janus International
JBI
$722M
| $150K | ﹤0.01% |
29,140
+15,286
| +110% | +$98.9K |
|
1172
Liberty Global Class C
LBTYK
$3.27B
| $150K | ﹤0.01% |
+12,786
| New | +$147K |
|
1173
DiaMedica Therapeutics
DMAC
$363M
| $149K | ﹤0.01% |
22,039
-1,533
| -7% | -$12.1K |
|
1174
Pacific Biosciences
PACB
$422M
| $149K | ﹤0.01% |
112,503
-93,907
| -45% | -$168K |
|
1175
Cognyte Software
CGNT
$612M
| $148K | ﹤0.01% |
+18,231
| New | +$150K |
|
Similar funds
NW
AAF
VA
FT
MWM
GGHC
DM
GRQ
Quadrature Capital's Q1 2026 Portfolio in Review
As of Q1 2026, Quadrature Capital held 2,005 positions worth $8.4B, down 14% from $9.8B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Quadrature Capital withdrew a net $1.42B in Q1 2026, closing 692 positions and reducing 256 holdings. Its most notable exit was Netflix, an estimated $156M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 24% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Quadrature Capital opened a new position in SPDR Gold Trust worth $231M.
- Quadrature Capital's largest Q1 2026 buy was SPDR Gold Trust: 537,107 shares worth $231M.
- Quadrature Capital added most to SAP in Q1 2026, an estimated $166M increase.
- Quadrature Capital's biggest Q1 2026 reduction was Sandisk, cutting an estimated $307M.
- Quadrature Capital fully exited Netflix in Q1 2026, selling an estimated $156M.
- Quadrature Capital's ten largest holdings make up 24% of its $8.4B portfolio in Q1 2026.
- Quadrature Capital opened 788 new positions and closed 692 in Q1 2026.
- Quadrature Capital's portfolio value fell 14% quarter-over-quarter to $8.4B.
Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.